N-(3-hydroxymethyl-β-carboline-1-yl-ethyl-2-yl)-L-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

• Main Authors: Wu JH (Author), Zhao M (Author), Wang YJ (Author), Wang YN (Author), Zhu HM (Author), Zhao SR (Author), Gui L (Author), Zhang XY (Author), Peng SQ (Author)
• Format: Book
• Published: Dove Medical Press, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Jianhui Wu,1–4 Ming Zhao,1–5 Yuji Wang,1–4 Yaonan Wang,1–4 Haimei Zhu,1–4 Shurui Zhao,1–4 Lin Gui,1–4 Xiaoyi Zhang,1–4 Shiqi Peng1–4 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, 2Enginee...